Primary Record
flufenamic acid
- In stock
- 9,545 g
- Purity
- 98.5 %
- CAS
- 530-78-9
Compound Identifiers & Properties
- CAS
- 530-78-9
- PubChem CID
- 3371
- SMILES
- C1=CC=C(C(=C1)C(=O)O)NC2=CC=CC(=C2)C(F)(F)F
- Canonical SMILES
- O=C(O)c1ccccc1Nc1cccc(C(F)(F)F)c1
Names & Synonyms
- flufenamic acid
- Arlef
- Achless
- Fluphenamic acid
- 530-78-9
- Nichisedan
- Tecramine
- Fullsafe
- Paraflu
- Parlef
- Flufenaminsaeure
- Acido flufenamico
- Flufacid
- Plostene
- Lanceat
- Meralen
- Parlif
- Surika
- Sastridex
- Ristogen
- Ansatin
- Reumajust A
- Acide flufenamique
- Flufenamicacid
- Flufenamate
- Acidum flufenamicum
- Fluore-200
- Dignodolin
- flufenamic-acid
- Acid, Flufenamic
- N-(3-Trifluoromethylphenyl)anthranilic acid
- Saal-F
- ANT-1
- Prestwick_220
- 2-((3-(Trifluoromethyl)phenyl)amino)benzoic acid
- Flufenaminsaeure [German]
- Arlef (TN)
- CI 440
- NSC-82699
- Acido flufenamico [Italian]
- C14H10F3NO2
- 60GCX7Y6BH
- 2-{[3-(trifluoromethyl)phenyl]amino}benzoic acid
- INF-1837
- Spectrum_001257
- 1bm7
- TVX 916
- LPEPZBJOKDYZAD-UHFFFAOYSA-N
- Opera_ID_578
- UNII-60GCX7Y6BH
- DTXSID7023063
- flufenamic acid aluminium
- MFCD00002422
- INF 1837
- 2-[3-(Trifluoromethyl)anilino]benzoic acid
- Prestwick0_000203
- Prestwick1_000203
- Prestwick2_000203
- Prestwick3_000203
- RefChem:388982
- Spectrum2_000789
- Spectrum3_001273
- Spectrum4_000102
- Spectrum5_000686
- CCRIS 5266
- CN-27,554
- Etofenamate EP Impurity A
- CHEBI:42638
- CHEMBL23588
- D0B2WJ
- Epitope ID:613429
- Acide flufenamique [INN-French]
- Acido flufenamico [INN-Spanish]
- Acidum flufenamicum [INN-Latin]
- Flufenamic acid (Standard)
- 2-[[3-(Trifluoromethyl)phenyl]amino]benzoic acid
- AC1L1FS8
- MLS000028563
- WLN: QVR BMR CXFFF
- DTXCID303063
- 3'-Trifluoromethyldiphenylamine-2-carboxylic acid
- CBiol_001756
- SCHEMBL17497
- BSPBio_000185
- BSPBio_001319
- BSPBio_002866
- CBDivE_012649
- FLUFENAMIC ACID [MI]
- KBioGR_000039
- KBioGR_000424
- KBioGR_002267
- KBioSS_000039
- KBioSS_001737
- KBioSS_002268
- KSC911Q2R
- MLS001148610
- C.I. 440
- DivK1c_000581
- FLUFENAMIC ACID [INN]
- FLUFENAMIC ACID [JAN]
- NSC 219007
- NSC-219007
- SPECTRUM1501015
- EINECS 208-494-1
- SPBio_000898
- SPBio_002106
- ACMC-209l43
- CI-440
- FLUFENAMIC ACID [USAN]
- AC1Q72G6
- BPBio1_000205
- GTPL2447
- orb1310228
- 2-(3-Trifluoromethylanilino)benzoic Acid
- FLUFENAMIC ACID [MART.]
- Flufenamic acid [USAN:INN:BAN:JAN]
- SCHEMBL29356958
- BCBcMAP01_000039
- BDBM17636
- Benzoic acid, 2-[[3-(trifluoromethyl)phenyl]amino]-
- CTK8B1828
- ERK5-2B07
- HMS501N03
- HY-B1221R
- KBio1_000581
- KBio2_000039
- KBio2_001737
- KBio2_002267
- KBio2_002607
- KBio2_004305
- KBio2_004835
- KBio2_005175
- KBio2_006873
- KBio2_007403
- KBio3_000077
- KBio3_000078
- KBio3_002366
- KBio3_002747
- ZINC86535
- BRN 1996069
- CID3371
- FLUFENAMIC ACID [WHO-DD]
- M01AG03
- MSK8002
- cMAP_000004
- NINDS_000581
- Bio1_000042
- Bio1_000531
- Bio1_001020
- Bio2_000039
- Bio2_000519
- CN-27554
- Flufenamic acid (JAN/USAN/INN)
- GLXC-27023
- HMS1361B21
- HMS1568J07
- HMS1791B21
- HMS1921B21
- HMS1989B21
- HMS2089E07
- HMS2092B09
- HMS2095J07
- HMS2232G24
- HMS3371F01
- HMS3402B21
- HMS3652F06
- HMS3712J07
- HMS3885P15
- HMS5082J22
- Pharmakon1600-01501015
- SMSSF-0062312
- CID:3371
- HY-B1221
- KS-000015VF
- N-[3-(Trifluoromethyl)phenyl]anthranilic acid
- NSC82699
- 2-((3-Trifluromethyl)phenyl)aminobenzoic acid
- Benzoic acid, 2-((3-(trifluoromethyl)phenyl)amino)-
- Tox21_110452
- Tox21_302111
- ANW-31633
- C14-H10-F3-N-O2
- CCG-40167
- EBC-04210
- HTS000643
- MSK8002-100A
- N-(m-Trifluoromethylphenyl)-2-aminobenzoic acid
- NCGC00016490-06
- NSC219007
- NSC757823
- s4268
- SBB001140
- STK985630
- CAS-530-78-9
- N-(alpha,alpha,alpha-Trifluoro-m-tolyl)anthranilic acid
- SMR000059027
- AKOS000265536
- MSK8002-1000A
- Tox21_110452_1
- C.I.440
- CS-4811
- DB02266
- FF23323
- Flufenamic acid [USAN:BAN:INN:JAN]
- J2.064H
- KS-1143
- NE10194
- NSC-757823
- Etofenamate EP Impurity A (Free Base)
- IDI1_000581
- IDI1_033789
- N-(3-Trifluoromethylphenyl)-anthranilic acid
- NCGC00016490-01
- NCGC00016490-02
- NCGC00016490-03
- NCGC00016490-04
- NCGC00016490-05
- NCGC00016490-07
- NCGC00016490-08
- NCGC00016490-09
- NCGC00016490-10
- NCGC00016490-12
- NCGC00023200-03
- NCGC00023200-04
- NCGC00023200-05
- NCGC00023200-06
- NCGC00023200-07
- NCGC00255175-01
- 2-[[3-(TRIFLUOROMETHYL)PHENYL]AMINO] BENZOIC ACID
- AJ-10755
- AK143107
- AN-16724
- BC207258
- CN-27544
- LS-20583
- M456
- SC-17641
- SID:53786933
- ST026563
- SY014664
- EC 208-494-1
- N-(3-Trifluoromethylphenyl)anthranilicAcid
- o-[m-(Trifluoromethyl)anilino]benzoic acid
- SBI-0051633.P002
- 2-(3-(trifluoromethyl)anilino)benzoic acid
- DB-052254
- RT-000369
- 2-[3-(trifluoromethyl)anilino]-benzoic acid
- 3-Trifluoromethyl-2 -carboxydiphenylamine
- AB00052198
- B1760
- ETOFENAMATE IMPURITY A [EP IMPURITY]
- FT-0603454
- n-(a,a,a-trifluoro-m-tolyl)anthranilic acid
- NS00000475
- ST24038963
- SW196528-3
- T2354
- UNM000001246003
- 2-[(3-Trifluromethyl)phenyl]aminobenzoic acid
- 2-[3-(Trifluoromethyl)anilino]benzoic acid #
- 3-14-00-00905 (Beilstein Handbook Reference)
- EN300-16858
- N-[(3-Trifluoromethyl)phenyl]anthranilic acid
- N-[3-(Trifluoromethyl)phenyl]anthanilic acid
- o-[m-(trifluoromethyl)phenylamino]benzoic acid
- 2-[(3-Trifluoromethylphenyl)amino]benzoic Acid
- A13333
- C13038
- D01581
- D97458
- AB00052198-14
- AB00052198_15
- F0909-0007
- 530F789
- A829389
- D005439
- F358173
- N-((m-Trifluoromethyl)phenyl)-2-aminobenzoic acid
- N-[(m-Trifluoromethyl)phenyl]-2-aminobenzoic acid
- N-[m-(Trifluoromethyl)phenyl]-2-aminobenzoic acid
- Q416341
- SR-01000000241
- 3'-Trifluoromethyldiphenylamine-2-carbox ylic acid
- Anthranilic acid, N-(alpha,alpha,alpha-trifluoro-m-tolyl)-
- Flufenamic acid Solution in Acetonitrile, 100ug/mL
- SR-01000000241-2
- SR-01000000241-3
- Anthranilic acid,.alpha.,.alpha.-trifluoro-m-tolyl)-
- BRD-K44067360-001-06-3
- BRD-K44067360-001-16-2
- BRD-K44067360-001-29-5
- BRD-K44067360-001-30-3
- Flufenamic acid Solution in Acetonitrile, 1000ug/mL
- I14-19098
- N-(.alpha.,.alpha.-Trifluoro-m-tolyl)anthranilic acid
- Z56797275
- Flufenamic acid, analytical standard, for drug analysis
- N-(.alpha.,.alpha.,.alpha.-Trifluoro-m-tolyl)anthranilic acid
- N-(alpha,alpha,alpha-trifluoro-m-tolyl)anthra-nilic acid
- 2-[(alpha,alpha,alpha-Trifluoro-m-tolyl)amino]benzoic acid
- FFA
- Flufenamic acid, 97%, an anti-inflammatory agent - 10G 10g
- Anthranilic acid, N-(.alpha.,.alpha.,.alpha.-trifluoro-m-tolyl)-
- FLF
- 208-494-1
- FFA, Flufenamic acid, 3-[(2-Carboxyphenyl)amino]benzotrifluoride, 2-Carboxy-3'-(trifluoromethyl)diphenylamine
- Flufenamic Acid; Etofenamate Imp. A (EP); 2-[3-(Trifluoromethyl)anilino]benzoic acid; 2-[[3-(Trifluoromethyl)phenyl]amino]benzoic acid; 3'-Trifluoromethyl-N-phenylanthranilic acid; 3'-Trifluoromethyldiphenylamine-2-carboxylic acid; ANT-1; Achless; Ansatin; Arlef; CI 440; CN 27544; Flufenamic acid; Fluphenamic acid; Fullsafe; INF 1837; Meralen; Movilizin; N-(m-Trifluoromethylphenyl)-2-aminobenzoic acid; N-[3-(Trifluoromethyl)phenyl]anthranilic acid; NSC 219007; NSC 82699; Paraflu; Parlef; Parlif; Pinox; Plostene; Ristogen; Sastridex; Surika; Tecramine; N-(alpha,alpha,alpha-Trifluoro-m-tolyl)anthranilic acid; Etofenamate Impurity A